LKT Labs, 1217486-61-7, Chemicals
1 - 1 of 1
Sort
View
Show
-
BYL719
LKT LabsBYL-719 is an ATP-competitive oral PI3K inhibitor selective for the p110a isoform that is activated by a mutant PIK3CA gene in HER2+ breast cancers and gastric cancers. BYL-719 exhibits anticancer chemotherapeutic activity and inhibits proliferation in a variety of cell lines. IGF1 and neuregulin 1…
Site Search by